Jeff Margolis Joins Predilytics Board of Directors

Healthcare I.T. pioneer and industry veteran to assist in driving strategic direction and adoption of company's unique predictive analytics solutions

Jul 24, 2013, 11:00 ET from Predilytics, Inc.

BURLINGTON, Mass., July 24, 2013 /PRNewswire/ -- Predilytics, the advanced predictive analytics company dedicated to answering healthcare's toughest questions, today announced the appointment of Jeff Margolis to its board of directors.  With nearly 30 years' experience in healthcare, Margolis brings the company unparalleled depth in starting and growing  businesses, a keen vision of healthcare's future direction, and practical understanding of the adoption and widespread deployment of healthcare technology.

Mr. Margolis is currently Chairman and CEO of WellTok®, Inc., the developer of CaféWell®, a platform that drives increased consumer engagement in health activities sponsored by their health plans.  Previous to joining WellTok, Margolis was the founder of healthcare services powerhouse TriZetto®, serving as its CEO from inception through IPO and then to a $1.4 billion leveraged buy-out.  He is also the well-known author of the book The Healthcare Cure, which delivers a penetrating and understandable look at the US healthcare system from both a management and a consumer standpoint.

"We are proud and pleased that Jeff Margolis has agreed to join the Predilytics Board of Directors," stated Patrick Flynn, Predilytics executive chairman.  "He has demonstrated strong stewardship of every company he has been involved with, and we know he will lend a steady hand to Predilytics as we innovate, grow and deliver value."

"I've been very impressed with the Predilytics team and their unique approach to healthcare predictive analytics," said new board member Jeff Margolis.  "Their application of analytic techniques that have proven value in other industries is just the sort of creative thinking we need more of, as we address our toughest healthcare population management challenges and opportunities."

"It is the truly exceptional executive who brings an early-stage company Jeff's combination of vision, focus and deep experience," summed up Michael Greeley, General Partner at Flybridge Capital Partners and a Predilytics board member.  "My fellow board members and I welcome him to the fold, and look forward to a productive strategic and working relationship."

About Predilytics
Predilytics is an advanced analytics company, the first to commercially employ in healthcare the analytic techniques and processes that have demonstrated proven, long-term success in such demanding industry sectors as financial services and consumer acquisition and engagement.

Predilytics applies patented machine-learning analytic tools to transform healthcare "big data", and to point the way for healthcare organizations to optimize and precisely target care delivery, increase their revenue, control costs, and improve population health.  Founded in 2011 and headquartered outside Boston in Burlington, MA, Predilytics is backed by investments led by Flybridge Capital Partners, Highland Capital Partners and Google Ventures.

© 2013. Predilytics, Inc. All rights reserved.



SOURCE Predilytics, Inc.